US2003004309A1PendingUtilityA1

Immunological enhancement agent comprising N-terminal peptide of p43 as an effective component

48
Priority: Jun 5, 2001Filed: Aug 16, 2001Published: Jan 2, 2003
Est. expiryJun 5, 2021(expired)· nominal 20-yr term from priority
Inventors:Sunghoon KimYoung-Gyu Ko
A61K 2039/55522A61K 38/00C07K 14/52A61P 37/04A61K 38/17
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to an immunological enhancement agent, more particularly, to an immunological enhancement agent comprising peptide having an amino acid sequence represented by SEQ ID NO:1 to SEQ ID NO:3 as an effective component. The peptides according to the present invention comprising the N-terminal domain of the p43 protein have excellent cytokine activity to improve an immune response so that they can be used as an effective immunological enhancement agent.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . An immunological enhancement agent comprising peptide represented by SEQ ID NO:1 as an effective component.  
     
     
         2 . An immunological enhancement agent comprising peptide represented by SEQ ID NO:2 as an effective component.  
     
     
         3 . An immunological enhancement agent comprising peptide represented by SEQ ID NO:3 as an effective component.

Join the waitlist — get patent alerts

Track US2003004309A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.